Role of health-related quality of life measures in the routine care of people with multiple sclerosis

Alessandra Solari, Alessandra Solari

Abstract

Health-related quality of life instruments are expected to be of particular value in routine care of people with multiple sclerosis (MS), where they may facilitate the detection of disease aspects that would otherwise go unrecognised, help clinicians appreciate patient priorities particularly in terms of treatment goals, facilitate physician-patient communication, and promote shared decision-making. However, it appears that these instruments are little used routine clinical approaches to people with MS. To address this issue, I performed a bibliographic search of studies that evaluated the efficacy of generic or disease-specific health-related quality of life (HRQOL) instruments in MS clinical practice from clinicians' or patients' perspectives. I found only one cross-sectional study, which compared preferences for three instruments, and assessed acceptability in people with MS. Reasons for lack of transfer of HRQOL measurements to clinical practice may be cultural, methodological, or practical. With regard to MS, the proliferation of instruments seems to constitute a barrier, with no particular instrument having gained wide popularity or consensus. Other barriers are lack of resources for the administration, collection and storage of the data, and inability of clinicians to score, interpret, and use HRQOL instrument to guide clinical care. It is therefore important to refine existing tools, extending clinical validation to wider contexts and cultures. More studies assessing acceptability and clinicians' and patients' preferences for different instruments are also required.

Figures

Figure 1
Figure 1
Number of publications on HRQOL in people with MS between 1992 and 2004. Blue bars indicate all studies on HRQOL; light blue bars indicate studies employing MS-specific instruments. Studies considering patient-reported outcomes other than HRQOL, or domain-specific measures are excluded.

References

    1. Compston A. Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997;62:553–561.
    1. Kurtzke JF. Geography in multiple sclerosis. J Neurol. 1977;215:1–26. doi: 10.1007/BF00312546.
    1. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci. 1993;20:17–29.
    1. Pittock SJ, McClelland RL, Mayr WT, Jorgesten NW, Weinshenker BG, Noseworthy J, Rodriguez M. Clinical implications of benign multiple sclerosis: A 20-year population-based follow-up study. Ann Neurol. 2004;56:303–306. doi: 10.1002/ana.20197.
    1. Filippini G, Munari L, Incorvaia B. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet. 2003;361:545–552. doi: 10.1016/S0140-6736(03)12512-3.
    1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology. 1983;33:1444–1452.
    1. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients and doctors perceptions and assessments of disability in multiple sclerosis. BMJ. 1997;314:1580–1583.
    1. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology. 1997;48:74–80.
    1. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci. 1996;23:99–103.
    1. Burden of illness of multiple sclerosis: Part II: Quality of life. The Canadian Burden of Illness Study Group. Can J Neurol Sci. 1998;25:31–38.
    1. Pfennings LEMA, Cohen L, Van der Ploeg HM. Assessing the quality of life in patients with multiple sclerosis. In: Thompson AJ, Polman C, Hohlfeld R, editor. Multiple sclerosis: clinical changes and controversies. London: Martin Dunitz; 1997.
    1. Lintern TC, Beaumont G, Kenealy PM, Murrell RC. Quality of life (QoL) in severely disabled multiple sclerosis patients: Comparison of three QoL measures using multidimensional scaling. Qual Life Res. 2001;10:371–378. doi: 10.1023/A:1012219504134.
    1. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4:187–206.
    1. Cella DF, Dineen MA, Arnason B, Reder A, Webster KA, karabatsos G, Chang C, Lloyd S, Steward J, Stefoski D. Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument. Neurology. 1996;47:129–139.
    1. Fischer JS, LaRocca NG, Miller DM, Ritvo PG, Andrews H, Paty D. Recent developments in the assessment of quality of life in multiple sclerosis (MS) Mult Scler. 1999;5:251–259. doi: 10.1191/135245899678846177.
    1. Rotstein Z, Barak Y, Noy S, Achiron A. Quality of life in multiple sclerosis: development and validation of the "RAYS" scale and comparison with the SF-36. Int J Qual Health Care. 2000;12:511–517. doi: 10.1093/intqhc/12.6.511.
    1. Gold SM, Heesen C, Schulz H, Guder U, Monch A, Gbadamosi J, Buhmann C, Schulz KH. Disease-specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in multiple sclerosis (HAQUAMS) Mult Scler. 2001;7:119–130. doi: 10.1191/135245801678227649.
    1. Hobart JC, Lamping DL, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124:962–973. doi: 10.1093/brain/124.5.962.
    1. Ford HL, Gerry E, Tennant A, Whalley D, Haigh R, Johnson MH. Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil. 2001;15:247–258. doi: 10.1191/026921501673658108.
    1. Solari A, Filippini G, Mendozzi L, Grezzi A, Cifani S, Barbieri E, Baldini S, Salmeggi A, LaMantia L, Farinotti M, Caputo D, Mosconi P. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry. 1999;67:158–162.
    1. Vernay D, Gerbaud L, Biolay S, Coste J, Debourse J, Aufauvre D, Beneton C, Colamarino R, Glandier PY, Dordain G, Clavelou P. Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59) Rev Neur. 2000;156:247–263.
    1. Acquadro C, Lafortune L, Mear I. Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes. 2003;1:70. doi: 10.1186/1477-7525-1-70.
    1. Yamamoto T, Ogata K, Katagishi M, Shimizu H, Ogawa M, Yamamura T, Kawai M. Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument. Rinsho Shinkeigaku. 2004;44:417–421.
    1. Mendes MF, Balsimelli S, Stangehaus G, Tilbery CP. Validation of the functional assessment of multiple sclerosis quality of life instrument in a Portuguese language. Arq Neuropsiquiatr. 2004;62:108–113.
    1. Lincoln NB, Dent A, Harding J, Weyman N, Nicholl C, Blumhardt LD, Playford ED. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002;72:93–98. doi: 10.1136/jnnp.72.1.93.
    1. Solari A, Motta A, Mendozzi L, Pucci E, Forni M, Mancardi G, Pozzilli C. Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial. J Neurol Sci. 2004;222:99–104. doi: 10.1016/j.jns.2004.04.027.
    1. Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN. Benefit of interferon β-1a on MSFC progression in secondary progressive MS. Neurology. 2002;59:679–687.
    1. Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, Reer R, Braumann KM, Heesen C. Impact of aerobic training on immune-endocrine parameters, neutrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci. 2004;225:11–18. doi: 10.1016/j.jns.2004.06.009.
    1. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H, Kristoferitsch W, Zeitlhofer J. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004;110:6–13. doi: 10.1111/j.1600-0404.2004.00257.x.
    1. Solari A, Radice D. Health status of people with multiple sclerosis: a community mail survey. Neurol Sci. 2001;22:307–315. doi: 10.1007/s10072-001-8173-8.
    1. Henriksson F, Fredrikson S, Masterman T, Jönsson Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol. 2001;8:27–35. doi: 10.1046/j.1468-1331.2001.00169.x.
    1. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue, and disability. Mult Scler. 2001;7:340–344. doi: 10.1191/135245801681138059.
    1. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. Int J Psychiatry Med. 2000;30:309–317.
    1. Grønning M, Hannisdal E, Mellgren SI. Multivariate analyses of factors associated with unemployment in people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1990;53:388–390.
    1. Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life measure of people with multiple sclerosis. Disabil Rehabil. 2001;23:516–521. doi: 10.1080/09638280010022090.
    1. Vickrey BG. Getting oriented to patient-oriented outcomes. Neurology. 1999;53:662–663.
    1. Note for guidance on clinical investigation of medicinal products for the treatment of multiple sclerosis last accessed March 2005.
    1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191–1194. doi: 10.1016/S0140-6736(00)04337-3.
    1. Moore F, Wolfson C, Alexandrov L, Lapierre Y. Do general and multiple sclerosis- specific quality of life instruments differ? Can J Neurol Sci. 2004;31:64–71.
    1. Deyo RA, Patrick DL. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care. 1989;27:S252–S268.
    1. McHorney CA, Taylor AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293–307.
    1. Rubenstein LV, McCoy JM, Cope DW, Barrett PA, Hirsch SH, Messer KS, Young RT. Improving patient quality of life with feedback to physicians about functional status. J Gen Intern Med. 1995;10:607–614.
    1. Nelson EC, Landgraf JM, Hays RD, Wasson JH, Kirk JW. The functional status of patients: how can it be measured in physician's offices? Med Care. 1990;28:1111–1126.
    1. Somerset M, Campbell R, Sharp DJ, Peters T. What do people with MS want and expect from health-care services? Health Expectations. 2001;4:29–37. doi: 10.1046/j.1369-6513.2001.00111.x.
    1. Kazis LE, Callahan LF, Meenan RF, Pincus TSO. Health status reports in the care of patients with rheumatoid arthritis. J Clin Epidemiol. 1990;43:1243–1253. doi: 10.1016/0895-4356(90)90025-K.
    1. Wagner AK, Ehrenberg BL, Tran TA, Bungay KM, Cynn DJ, Rogers WH. Patient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care. Qual Life Res. 1997;6:329–341. doi: 10.1023/A:1018479209369.
    1. Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry. 2002;180:101–103. doi: 10.1192/bjp.180.2.101.
    1. Lee SJ, Joffe S, Kim HT, Socie G, Gilman AL, Wingard JR, Horowitz MM, Cella D, Syrjala KL. Physicians' attitudes about quality of life issues in haematopoietic stem cell transplantation. Blood. 2004;104:2194–2200. doi: 10.1182/blood-2003-07-2430.
    1. Donaldson MS. Tacking stock of health-related quality-of-life measurement in oncology practice in the United States. J Natl Cancer Inst Monogr. 2004;33:155–167. doi: 10.1093/jncimonographs/lgh017.
    1. Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I: Applications and issues in assessment. BMJ. 1992;305:1074–1077.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit